Using Droplet Digital™ PCR for Cancer and Liquid Biopsy Studies

5 April 2016

In this video from Bio-Rad, you can listen to Dr Dawne Shelton describe how Droplet Digital PCR technology is being used to identify cancer subtypes, optimize drug treatment plans, monitor residual disease and study tumor evolution. Droplet Digital PCR assays offer advantages in liquid biopsies by enabling the measurement of circulating nucleic acid and circulating tumor cells in blood. Learn more about these techniques and methods in this recorded webinar.